Invention Grant
- Patent Title: Ibrutinib intermediate compounds, preparation methods and uses thereof
-
Application No.: US15321750Application Date: 2015-04-21
-
Publication No.: US10023542B2Publication Date: 2018-07-17
- Inventor: Yunyu Hua , Xianyi Zhang , Hongjun Gao , Yuanqiang Li , Daqing Che
- Applicant: Zhejiang Jiuzhou Pharma science&technology Co., Ltd
- Applicant Address: CN Taizhou Zhenjiang
- Assignee: Zhejiang Jiuzhou Pharmaceuticals Co., Ltd
- Current Assignee: Zhejiang Jiuzhou Pharmaceuticals Co., Ltd
- Current Assignee Address: CN Taizhou Zhenjiang
- Priority: CN201410313610 20140703
- International Application: PCT/CN2015/077039 WO 20150421
- International Announcement: WO2016/000476 WO 20160107
- Main IPC: C07D239/26
- IPC: C07D239/26 ; C07D487/04
Abstract:
The present invention relates to the technical field of ibrutinib, particularly to the technical field of ibrutinib intermediate compounds and preparation methods thereof. The intermediate compounds are represented by formula A, wherein, the dotted line represents a double bond or a single bond between carbon and oxygen.
Public/Granted literature
- US20170137386A1 IBRUTINIB INTERMEDIATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Public/Granted day:2017-05-18
Information query
